Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Intravenous immunoglobulin. This is a controversial and expensive therapy that has been proposed for women with a history of recurrent miscarriages or recurrent implantation failures. The Practice Committee of the ASRM issued a statement in 2006 indicating that IVIG should be considered an experimental treatment for the management of recurrent pregnancy loss.
